Literature DB >> 22640727

Is omentectomy mandatory in the operation for ovarian cancer? Preliminary results in a rat study.

Yoshihito Yokoyama1, Hachidai Hirakawa, Hui Wang, Hideki Mizunuma.   

Abstract

OBJECTIVE: To investigate whether omentectomy is required in the operation for ovarian cancer, in particular at the early stage. STUDY
DESIGN: F344 nude rats were divided into two groups: one in which laparotomy and omentectomy were performed (primary omentectomy group, n=6) and one without omentectomy (n=12). Concurrently, DISS cells derived from ovarian cancer were transplanted intraperitoneally. After three weeks, the 12 rats without omentectomy were divided into two more groups: one in which the omentum was resected together with the tumor (sham operation/omentectomy group, n=6) and one without omentectomy (sham operation alone group, n=6).
RESULTS: The survival of the sham operation alone group was shortest with a median of 35 days, while the median of the primary omentectomy group was 42 days. In the sham operation/omentectomy group, four rats survived beyond Day 90, which was significant compared with other two groups. The intraperitoneal findings in the primary omentectomy group revealed extensive disseminated foci on the mesentery and under the abdominal wall. The sham operation alone group was characterized by jaundice resulting from the compression of the biliary system at the liver hilum by the omental mass. Disseminated foci were not observed in the peritoneal cavity from the sham operation/omentectomy group.
CONCLUSIONS: This study suggests the possibility that the omentum has a role in capturing cancer cells and suppressing further peritoneal dissemination. Therefore, although omentectomy is rewarding if disseminated foci are present in the omentum, it is suggested that the timing of omentectomy requires reconsideration in the absence of omental metastasis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22640727     DOI: 10.1016/j.ejogrb.2012.05.020

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Generation of a dual-functioning antitumor immune response in the peritoneal cavity.

Authors:  Abigail L Sedlacek; Scott A Gerber; Troy D Randall; Nico van Rooijen; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2013-08-08       Impact factor: 4.307

2.  IKK-ε coordinates invasion and metastasis of ovarian cancer.

Authors:  Sarah Hsu; Marianne Kim; Lidia Hernandez; Valentina Grajales; Anne Noonan; Miriam Anver; Ben Davidson; Christina M Annunziata
Journal:  Cancer Res       Date:  2012-08-31       Impact factor: 12.701

3.  Sentinel or Selective Omentectomy in Epithelial Ovarian Cancer: New Perspective.

Authors:  Ahmed Samy El-Agwany
Journal:  Indian J Surg Oncol       Date:  2021-01-03

4.  Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.

Authors:  WonJae Lee; Song Yi Ko; Muhaned S Mohamed; Hilary A Kenny; Ernst Lengyel; Honami Naora
Journal:  J Exp Med       Date:  2018-12-19       Impact factor: 14.307

5.  4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression.

Authors:  Ryosuke Tamura; Yoshihito Yokoyama; Hidemi Yoshida; Tadaatsu Imaizumi; Hideki Mizunuma
Journal:  J Ovarian Res       Date:  2014-10-11       Impact factor: 4.234

6.  Is omentectomy necessary in the treatment of benign or malignant abdominal pathologies? A systematic review.

Authors:  Arif Atay; Osman Nuri Dilek
Journal:  World J Gastrointest Surg       Date:  2021-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.